血清睾酮水平与男性年龄相关肾小球滤过率下降无关:基于Iohexol清除率的前瞻性研究
该研究基于普通人群800名50-62岁男性,采用血浆碘海醇清除率测量mGFR,中位随访10.9年,探讨总睾酮、游离睾酮及SHBG与年龄相关mGFR下降的关系。结果显示总睾酮和SHBG与基线mGFR较高相关,但三者均与mGFR下降速率或加速下降无关。结论认为睾酮并非男性年龄相关GFR下降的危险因素。
要点
- 在50-62岁普通男性中,总睾酮、游离睾酮和SHBG均与mGFR下降速率无关。
- 总睾酮和SHBG较高者基线mGFR较高,但未影响后续下降。
- 睾酮与肌肉量相关可能干扰eGFR,采用mGFR未发现其与GFR下降相关。
核心结论
- 在50-62岁普通男性中,血清总睾酮、游离睾酮和SHBG与年龄相关mGFR下降无显著关联。
研究设计与样本
- 前瞻性队列研究,纳入800名50-62岁普通男性,无自报心血管病、糖尿病或肾病。
- 2007-2009年基线行血浆碘海醇清除率测量mGFR,2013-2015年随访656人,2018-2020年随访578人。
- 中位随访10.9年,采用线性混合模型和逻辑回归分析睾酮、SHBG与mGFR下降及加速下降(下降最快10%,≥-1.64 mL/min/1.73 m2/年)的关联。
主要发现
- 总睾酮每升高1 nmol/L,基线mGFR高0.27 ml/min/1.73 m2(95%CI 0.09-0.45);SHBG每升高10 nmol/L,基线mGFR高0.79 ml/min/1.73 m2(95%CI 0.18-1.41)。
- 总睾酮每升高1 nmol/L,mGFR年下降为-0.02 ml/min/1.73 m2(95%CI -0.04至0.01)。
- 游离睾酮每升高1 nmol/L,mGFR年下降为-0.03 ml/min/1.73 m2(95%CI -0.15至0.08)。
- SHBG每升高10 nmol/L,mGFR年下降为-0.04 ml/min/1.73 m2(95%CI -0.12至0.05)。
临床怎么用
- 对于50-62岁男性,血清睾酮水平不宜作为年龄相关肾功能下降的风险评估指标。
- 临床评估肾功能时应优先采用mGFR或胱抑素C等不受肌肉量影响的指标,避免eGFR因睾酮与肌肉量关联产生偏倚。
局限性
- 研究人群限于50-62岁无自报心血管病、糖尿病或肾病的普通男性,结论外推需谨慎。
- 随访期间存在失访(基线800人,第二次随访656人,第三次578人)。
- 仅检测基线睾酮和SHBG,未评估随访期间激素水平变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Testosterone has been hypothesized to contribute to glomerular filtration rate (GFR) decline in males through its effects on kidney cells and the renin-angiotensin system. However, prior research relied on creatinine-based estimated GFR (eGFR), which may be biased by the association between testosterone and muscle mass, as increased muscle mass raises serum creatinine independently of true GFR. Here, we investigate the association between serum levels of total testosterone (TT), free testosterone (FT), and sex hormone-binding globulin (SHBG) and age-related decline in measured GFR (mGFR). METHODS: We included a representative sample of 800 males aged 50-62 years old from the general population without self-reported cardiovascular disease, diabetes, or kidney disease. All participants underwent plasma iohexol clearance measurements between 2007-2009, with follow-ups in 2013-2015 (656 individuals) and 2018-2020 (578 individuals). The association of FT, TT, and SHBG with mGFR decline and accelerated mGFR decline, defined as the 10% with the steepest GFR decline (-1.64 mL/min per 1.73 m2 or more per year), was assessed using linear mixed models and logistic regression. RESULTS: Both TT and SHBG were associated with a higher mGFR at baseline (0.27 ml/min/1.73 m2 [95% confidence interval: 0.09-0.45] per 1 nmol/L higher TT and 0.79 ml/min per 1.73 m2 [0.18- 1.41] per 10 nmol/L higher SHBG). Neither TT, FT, nor SHBG were associated with mGFR decline in the multivariable-adjusted linear mixed model analyses (-0.02 [-0.04 to 0.01] and -0.03 [-0.15 to 0.08] ml/min per 1.73 m2 per year for each nmol/L increase in TT and FT, respectively, and -0.04 [-0.12 to 0.05] ml/min per 1.73 m2 per year for each 10 nmol/L increase in SHBG). CONCLUSIONS: Testosterone was not associated with age-related GFR decline in males aged 50 to 62 years at baseline in the general population over a median follow-up of 10.9 years.
引用
- Saastad V, Rinde LB, Enoksen IT, et al. The Renal Iohexol Clearance Survey examined whether testosterone is a risk factor for age-related measured glomerular filtration rate decline in males. Kidney Int. 2026. PMID: 42749053. doi:10.1016/j.kint.2026.07.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。